IRIS
FRANCO, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.693
AS - Asia 1.346
EU - Europa 1.036
SA - Sud America 184
AF - Africa 96
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.363
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.633
CN - Cina 476
SG - Singapore 338
IE - Irlanda 264
VN - Vietnam 214
HK - Hong Kong 167
RU - Federazione Russa 166
BR - Brasile 132
IT - Italia 121
DE - Germania 116
FI - Finlandia 104
ZA - Sudafrica 70
FR - Francia 66
GB - Regno Unito 48
UA - Ucraina 34
CA - Canada 30
IN - India 30
BD - Bangladesh 25
CZ - Repubblica Ceca 21
MX - Messico 20
BE - Belgio 18
SE - Svezia 16
AR - Argentina 14
CO - Colombia 11
JP - Giappone 11
NL - Olanda 11
PL - Polonia 11
TR - Turchia 11
IQ - Iraq 10
ES - Italia 9
AT - Austria 8
EC - Ecuador 8
PK - Pakistan 8
AU - Australia 7
LT - Lituania 7
PH - Filippine 7
UZ - Uzbekistan 7
IL - Israele 5
MA - Marocco 5
PE - Perù 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
KE - Kenya 4
MU - Mauritius 4
UY - Uruguay 4
VE - Venezuela 4
AZ - Azerbaigian 3
CL - Cile 3
JO - Giordania 3
KG - Kirghizistan 3
CG - Congo 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GR - Grecia 2
HR - Croazia 2
ID - Indonesia 2
LK - Sri Lanka 2
LV - Lettonia 2
MY - Malesia 2
PA - Panama 2
PY - Paraguay 2
SI - Slovenia 2
TH - Thailandia 2
TJ - Tagikistan 2
TW - Taiwan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
GN - Guinea 1
IS - Islanda 1
JM - Giamaica 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MD - Moldavia 1
NE - Niger 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
Totale 4.363
Salva come PNG Salva come JPEG
Città #
Dublin 264
Ashburn 229
Chandler 204
Singapore 197
San Jose 174
Hong Kong 158
Beijing 145
Dallas 116
Ho Chi Minh City 69
Johannesburg 66
Boardman 64
Helsinki 53
Ann Arbor 52
Los Angeles 51
Hanoi 49
Lauterbourg 49
Munich 46
Jacksonville 42
Nanjing 41
Princeton 41
Lawrence 40
Moscow 34
New York 30
Shanghai 30
Medford 29
Turku 27
Redondo Beach 26
Wilmington 26
Hebei 24
Changsha 22
Buffalo 19
Milan 19
Nanchang 18
Brussels 17
São Paulo 17
Brno 16
Pavia 16
Woodbridge 15
Orem 14
Brooklyn 13
Frankfurt am Main 13
The Dalles 13
Toronto 13
Chicago 12
Piscataway 12
Shenyang 12
Da Nang 11
Tokyo 11
Warsaw 11
Jiaxing 10
Montreal 10
Phoenix 10
Rome 10
Council Bluffs 9
Houston 9
Mexico City 9
Seattle 9
Atlanta 8
Tianjin 8
Boston 7
Nuremberg 7
San Francisco 7
Santa Clara 7
Stockholm 7
Baghdad 6
Chennai 6
Denver 6
Guangzhou 6
Haiphong 6
Istanbul 6
Rio de Janeiro 6
Biên Hòa 5
Brasília 5
Campinas 5
Columbus 5
Dhaka 5
Florence 5
Hangzhou 5
Manchester 5
Medellín 5
Mumbai 5
Nha Trang 5
Norwalk 5
Poplar 5
Tashkent 5
Turin 5
Washington 5
Wuhan 5
Amsterdam 4
Bắc Ninh 4
Curitiba 4
Fairfield 4
Falkenstein 4
Giv‘atayim 4
Guarulhos 4
London 4
Nairobi 4
Quận Ba 4
Xian 4
Aachen 3
Totale 2.971
Salva come PNG Salva come JPEG
Nome #
A simple and rapid HPLC-UV method for the determination of retigabine in human plasma 166
A novel enantioselective microassay for the high-performance liquid chromatography determination of oxcarbazepine and its active metabolite monohydroxycarbazepine in human plasma 158
Development and validation of an HPLC-UV detection assay for the determination of rufinamide in human plasma and saliva. 151
Changes in lamotrigine pharmacokinetics during pregnancy and the puerperium. 127
Stereoselective determination of vigabatrin enantiomers in human plasma by high performance liquid chromatography using UV detection. 125
Characteristics of a large population of patients with refractory epilepsy attending tertiary referral centers in Italy. on behalf of the SOPHIE Study Group. 125
Determination of Perampanel in Dried Plasma Spots: Applicability to Therapeutic Drug Monitoring 112
Curcumin and Novel Synthetic Analogs in Cell-Based Studies of Alzheimer's Disease 108
Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in Europe 108
Development and validation of an HPLC-UV assay for the therapeutic monitoring of the new antiepileptic drug perampanel in human plasma 106
2β-3,4-Unsaturated sialic acid derivatives: Synthesis optimization, and biological evaluation as Newcastle disease virus hemagglutinin-neuraminidase inhibitors 104
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol 101
Does screening for adverse effects improve health outcomes in epilepsy? A randomized trial 95
Activity of FAAH-Inhibitor JZP327A in an Experimental Rat Model of Migraine 94
Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine 94
Perampanel effects in the WAG/Rij rat model of epileptogenesis, absence epilepsy, and comorbid depressive-like behavior 93
Novel treatment options for epilepsy: Focus on perampanel 92
Relationship between saliva and plasma rufinamide concentrations in patients with epilepsy 92
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy 92
Antiepileptic drugs and brain maturation: Fetal exposure to lamotrigine generates cortical malformations in rats. 90
Therapeutic Salivary Monitoring of Perampanel in Patients with Epilepsy Using a Volumetric Absorptive Microsampling Technique 88
Challenges in the clinical development of new antiepileptic drugs 88
Adverse events, placebo and nocebo effects in placebo-treated paediatric patients with refractory focal epilepsies. Analysis of double-blind studies 88
CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects 87
Analysis of nocebo effects of antiepileptic drugs across different conditions 85
Author Response: Does Screening for Adverse Effects Improve Health Outcomes in Epilepsy? A Randomized Trial 83
Cenobamate: A Review of its Pharmacological Properties, Clinical Efficacy and Tolerability Profile in the Treatment of Epilepsy 82
Melatonin versus Sleep Deprivation for Sleep Induction in Nap Electroencephalography: Protocol for a Prospective Randomized Crossover Trial in Children and Young Adults with Epilepsy 81
Fate of melatonin orally administered in preterm newborns: Antioxidant performance and basis for neuroprotection 80
Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research 80
Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2 79
Effects of the Dual FAAH/MAGL Inhibitor AKU-005 on Trigeminal Hyperalgesia in Male Rats 78
Peripheral Endocannabinoid Components and Lipid Plasma Levels in Patients with Resistant Migraine and Co-Morbid Personality and Psychological Disorders: A Cross-Sectional Study 74
Pediatric adverse reactions to antiseizure medications – An analysis of data from the Italian spontaneous reporting system (2001–2019) 74
The pharmacogenomics of epilepsy 73
Off-Label Prescribing of Antiepileptic Drugs in Pharmacoresistant Epilepsy: A Cross-Sectional Drug Utilization Study of Tertiary Care Centers in Italy 72
On-Line Solid Phase Extraction High Performance Liquid Chromatography Method Coupled With Tandem Mass Spectrometry for the Therapeutic Monitoring of Cannabidiol and 7-Hydroxy-cannabidiol in Human Serum and Saliva 71
Zonisamide in the management of epilepsy in the elderly 61
Design, Synthesis, and Antiviral Evaluation of Sialic Acid Derivatives as Inhibitors of Newcastle Disease Virus Hemagglutinin-Neuraminidase: A Translational Study on Human Parainfluenza Viruses 53
Straightforward access to 2,3- and 3,4-unsaturated derivatives of N-glycolylneuraminic acid 53
Profile of pitolisant in the management of narcolepsy: Design, development, and place in therapy 52
The adverse event profile of levetiracetam: A meta-analysis on children and adults 52
Do antiepileptic drugs increase the risk of infectious diseases? A meta-analysis of placebo-controlled studies 51
Perspective on the use of perampanel and intravenous carbamazepine for generalized seizures 50
Effects of eslicarbazepine acetate on lipid profile and sodium levels in patients with epilepsy 47
The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations 47
Pharmacological aspects of antiseizure medications: From basic mechanisms to clinical considerations of drug interactions and use of therapeutic drug monitoring 44
Tolerability of new antiepileptic drugs: a network meta-analysis 42
LC-MS/MS-Based Determination of Ambroxol in Human Plasma and Cerebrospinal Fluid: Validation and Applicability in a Phase II Study on GBA-Associated Parkinson’s Disease Patients 42
Targeting α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy 41
Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy 41
Interplay of Modified Sialic Acid Inhibitors and the Human Parainfluenza Virus 1 Hemagglutinin-Neuraminidase Active Site 35
Pharmacokinetic Interactions Between Antiseizure and Psychiatric Medications 35
Solubility of lamotrigine in age-specific biorelevant media that simulated the fasted- and fed-conditions of the gastric and intestinal environments in pediatrics and adults: implications for traditional, re-formulated, modified, and new oral formulations 34
Automated Workflow for High-Throughput LC–MS/MS Therapeutic Monitoring of Cannabidiol and 7-Hydroxy-cannabidiol in Patients with Epilepsy 31
The effects of daylight saving time and clock time transitions on sleep and sleepiness: a systematic review 27
Sleep profile in patients with septo-optic-pituitary dysplasia: protocol for a prospective cohort study 25
Totale 4.459
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.732
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.732
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202134 0 0 0 0 0 0 0 0 0 9 16 9
2021/2022171 2 2 7 2 2 1 2 7 11 5 32 98
2022/2023640 80 62 5 35 54 44 0 36 288 7 21 8
2023/2024301 49 24 14 23 28 67 14 32 2 9 26 13
2024/2025894 41 55 19 17 19 75 57 41 237 33 113 187
2025/20261.979 155 135 208 202 290 86 426 160 217 100 0 0
Totale 4.459